23014 results for "ega"

in 35.42 milliseconds.

• Lifelines-NEXT newborn cohort

  Study EGAS00001007592

• Sequencing of Ovarian Cancer

  Study EGAS00001007489

• Sequencing of Breast Cancer

  Study EGAS00001007490

• University Health Network DAC

  Dac EGAC00001003401

• MDA-DAC-IOTOX-IMT

  Dac EGAC00001003448

• BostonGene Data Access Committee

  Dac EGAC00001002683

• CDRMR Data Access Committee

  Dac EGAC00001002763

• Buccal Sample Methylation DAC

  Dac EGAC00001003469

• Targeted sequencing of MBD4

  Dac EGAC00001001986

• DAC Barretos Cancer Hospital

  Dac EGAC50000000013

• EpiFemCare clinical steering board

  Dac EGAC00001000781

• CIMH

  Dac EGAC00001003002

• Parkinson's Families Project DAC

  Dac EGAC00001003499

• UZ/KU Leuven DAC

  Dac EGAC00001003121

• MPIMG DAC

  Dac EGAC50000000149

• ID1 in glioblastoma

  Study EGAS00001003711

• EAC Genomic data

  Study EGAS00001004887

• Retinal Dystrophy_analysis

  Study EGAS00001005369

• Pearl study

  Study EGAS00001005523

• JEM 20211004R

  Study EGAS00001005764

• Acne GWAS meta-analysis

  Study EGAS00001005772

• RCC Xenografts EuroTARGET DAC

  Dac EGAC00001002379

• Brain Cancer Center Committee

  Dac EGAC50000000456

• INFORM DAC

  Dac EGAC00001001829

• CANCAP03 Data Access Committee

  Dac EGAC50000000508

• PANGEA-HIV consortium

  Dac EGAC50000000493

• PacBio Rare Disease Study - DAC

  Dac EGAC00001003560

• LUMC Nephrology - kidney organoids

  Dac EGAC50000000622

• OMKar Study Data Access Committee

  Dac EGAC00001003581

• Islet Group Leiden

  Dac EGAC50000000558

• Curie Data Access Committee

  Dac EGAC00001003488

• CHIP and LOY in AD

  Dac EGAC00001003606

• Peter Mac Data Governance

  Dac EGAC50000000764

• MOMA - Prostate group DAC

  Dac EGAC50000000879

• Proteogenomics Data Access Committee

  Dac EGAC50000000386

• Clinical validity of post-surgery circulating tumor DNA (ctDNA) in stage III colon cancer patients treated with adjuvant chemotherapy: the PROVENC3 study

  The PROVENC3 study aimed to determine the clinical validity of post-surgery ctDNA testing in patients with stage III colon cancer treated with adjuvant chemotherapy (ACT). Blood was collected pre-surgery, post-surgery and post-adjuvant chemotherapy. Tumor-informed plasma ctDNA detection was performed through integrated whole genome sequencing (WGS) analyses of formalin-fixed paraffin-embedded tumor tissue DNA (80x), white blood cell germline DNA (40x) and plasma cell-free DNA (30x). These raw WGS data for 209 patients are shared in .cram format in this EGA submission. For 196/209 of these patients there is overlapping FFPE tumor RNA sequencing data available, shared in .fastq format in this EGA submission.

  Study EGAS50000000804

• MD Anderson Melanoma Genomic Medicine

  Dac EGAC00001000324

• DAC of TGDL at Stanford

  Dac EGAC00001002601

• DAC of TGDL at Stanford

  Dac EGAC00001002602

• Data Access Commitee epithelioid sarcoma

  Dac EGAC00001003250

• Erasmus MC COVID-19 DAC

  Dac EGAC00001002851

• DAC-AML-Smart-2023

  Dac EGAC00001003232

• DS-ALL RNA-Seq DAC

  Dac EGAC00001002866

• Melanoma RNA Seq Data commitee

  Dac EGAC00001002928

• DAC of the BriTROC-1 project

  Dac EGAC00001003291

• ZPM WES Pilot DAC

  Dac EGAC00001003313

• TGCT Germline Exome Sequencing Study

  Dac EGAC00001000944

• NCD-GHS Data Access Commitee

  Dac EGAC00001003119

• InstituteForSurgicalPathologyFreiburg

  Dac EGAC00001003260

• DAC Human Skeletal Muscles Transcriptome

  Dac EGAC00001002603